1. Home
  2. GOSS vs INGN Comparison

GOSS vs INGN Comparison

Compare GOSS & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • INGN
  • Stock Information
  • Founded
  • GOSS 2015
  • INGN 2001
  • Country
  • GOSS United States
  • INGN United States
  • Employees
  • GOSS N/A
  • INGN N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • INGN Industrial Specialties
  • Sector
  • GOSS Health Care
  • INGN Health Care
  • Exchange
  • GOSS Nasdaq
  • INGN Nasdaq
  • Market Cap
  • GOSS 230.8M
  • INGN 260.2M
  • IPO Year
  • GOSS 2019
  • INGN 2014
  • Fundamental
  • Price
  • GOSS $0.95
  • INGN $9.08
  • Analyst Decision
  • GOSS Strong Buy
  • INGN Hold
  • Analyst Count
  • GOSS 5
  • INGN 4
  • Target Price
  • GOSS $9.20
  • INGN $7.00
  • AVG Volume (30 Days)
  • GOSS 939.3K
  • INGN 190.5K
  • Earning Date
  • GOSS 11-07-2024
  • INGN 11-05-2024
  • Dividend Yield
  • GOSS N/A
  • INGN N/A
  • EPS Growth
  • GOSS N/A
  • INGN N/A
  • EPS
  • GOSS N/A
  • INGN N/A
  • Revenue
  • GOSS $95,842,000.00
  • INGN $326,653,000.00
  • Revenue This Year
  • GOSS N/A
  • INGN $5.76
  • Revenue Next Year
  • GOSS N/A
  • INGN $4.10
  • P/E Ratio
  • GOSS N/A
  • INGN N/A
  • Revenue Growth
  • GOSS N/A
  • INGN N/A
  • 52 Week Low
  • GOSS $0.45
  • INGN $4.13
  • 52 Week High
  • GOSS $1.60
  • INGN $13.33
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 46.34
  • INGN 27.81
  • Support Level
  • GOSS $0.98
  • INGN $8.85
  • Resistance Level
  • GOSS $1.09
  • INGN $9.33
  • Average True Range (ATR)
  • GOSS 0.06
  • INGN 0.39
  • MACD
  • GOSS -0.01
  • INGN -0.06
  • Stochastic Oscillator
  • GOSS 11.44
  • INGN 16.82

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About INGN Inogen Inc

Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.

Share on Social Networks: